The inhibitory receptor LILRB4 (ILT3) modulates antigen presenting cell phenotype and, along with LILRB2 (ILT4), is upregulated in response to Salmonella infection

被引:51
|
作者
Brown, Damien P. [2 ]
Jones, Des C. [2 ]
Anderson, Katie J. [1 ]
Lapaque, Nicolas [2 ]
Buerki, Robin A. [2 ,3 ]
Trowsdale, John [2 ]
Allen, Rachel L. [1 ]
机构
[1] Univ London, Div Cellular & Mol Med, Ctr Infect, London, England
[2] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England
[3] Northwestern Univ, Evanston, IL USA
基金
英国惠康基金;
关键词
DENDRITIC CELLS; EXPRESSION; HYPORESPONSIVENESS; INTERLEUKIN-10; TOLERIZATION; INNATE; CANCER; MICE;
D O I
10.1186/1471-2172-10-56
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Leukocyte Ig-like receptors (LILR) are a family of innate immune receptors with immunomodulatory functions. High-level expression of the receptors LILRB2 (ILT4) and LILRB4 (ILT3) is a feature of tolerogenic antigen presenting cells and has been observed in cancer and transplant situations. There are relatively few studies regarding these receptors in the context of infection and it is not yet clear how LILRB4 exerts its inhibitory effects. Results: We studied the effects of LILRB4 ligation on antigen presenting cell phenotype, and the expression of LILRB2 and LILRB4 on Salmonella-infected antigen presenting cells. Ligation of LILRB4 throughout in vitro culture of dendritic cells led to an upregulation of the co-stimulatory protein CD86. Alterations in the production of IL-8 and IL-10 by LILRB4-ligated macrophages were also observed. Infection with Salmonella typhimurium or TLR stimulation with Salmonella components led to an upregulation of LILRB2 and LILRB4. Conclusion: Our results indicate that the inhibitory effects of LILRB4 do not result from a failure to upregulate co-stimulatory proteins. In addition to the high level expression that can render antigen presenting cells tolerogenic, there may be a role for lower level expression and activity of LILRB2 and LILRB4 in response to TLR signalling during an immune response to bacterial infection.
引用
收藏
页数:9
相关论文
共 25 条
  • [1] The inhibitory receptor LILRB4 (ILT3) modulates antigen presenting cell phenotype and, along with LILRB2 (ILT4), is upregulated in response to Salmonella infection
    Damien P Brown
    Des C Jones
    Katie J Anderson
    Nicolas Lapaque
    Robin A Buerki
    John Trowsdale
    Rachel L Allen
    BMC Immunology, 10
  • [2] Haplotypes of the LILRB2 (ILT4) gene and predisposition for autoimmunity
    Wagner, Nadine
    Remus, Ralph
    Hallmann, Katja
    Hardt, Cornelia
    TISSUE ANTIGENS, 2009, 73 (05): : 406 - 406
  • [3] LILRB4 (ILT3): a candidate gene for predisposition to autoimmune diseases
    Kraczyk, Britta
    Remus, Ralph
    Hallmann, Katja
    Hardt, Cornelia
    TISSUE ANTIGENS, 2009, 73 (05): : 404 - 405
  • [4] BLOCKADE OF HUMAN LILRB4/ILT3 INHIBITS THE FORMATION OF LUNG METASTASIS IN MELANOMA MODEL
    Khantakova, Darya
    Molgora, Martina
    Roda, Julie
    Stone, Geoffrey
    Gilfillan, Susan
    Trsan, Tihana
    Cella, Marina
    Kutach, Alan
    Kaplan, Daniel
    Hsu, Jer-Yuan
    Colonna, Marco
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A870 - A870
  • [5] Overexpression of LILRB2 (ILT4) is correlated with immunosuppressive immune infiltration in lung adenocarcinoma.
    Li, Butuo
    Jiang, Chao
    Wang, Shijiang
    Li, Xuanzong
    Xu, Yiyue
    Fan, Xinyu
    Yu, Jinming
    Wang, Linlin
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [6] A deep characterization of the LILRB2/ILT4 genetic variability in Brazilian samples with different ancestry compositions
    Castelli, E. C.
    Oliveira, M. G.
    Veiga-Castelli, L. C.
    Souza, A. S.
    Lima, T. H. A.
    Andrade, H. S.
    Weiss, E.
    Passos, M. R. S.
    Marcorin, L.
    Debortoli, G.
    Pereira, A. L. E.
    Fracasso, N. C. A.
    Valente, G. V.
    Sabbagh, A.
    Mendes-Junior, C. T.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1915 - 1915
  • [7] Augmented ILT3/LILRB4 Expression of Peripheral Blood Antibody Secreting Cells in the Acute Phase of Kawasaki Disease
    Sugahara-Tobinai, Akiko
    Inui, Masanori
    Metoki, Takaya
    Watanabe, Yohei
    Onuma, Ryoichi
    Takai, Toshiyuki
    Kumaki, Satoru
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2019, 38 (04) : 431 - 438
  • [8] Antibodies to ILT3 (LILRB4) abrogate myeloid immunosuppression and combine with PD1 blockade to enable T cell activation and function
    Brandish, Philip
    Baker, Jeanne
    Byford, Alan
    Caniga, Michael
    Chappell, Craig
    Cherwinski, Holly
    Cua, Daniel
    Fayadat-dilman, Laurence
    Hall, Brian
    Joyce-Shaikh, Barbara
    Juan, Veronica
    Mieczkowski, Carl
    Palmieri, Anthony
    Qu, Yujie
    Singh, Latika
    Stiivers, Peter
    Zhang-Hoover, Jie
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [9] HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells
    LeMaoult, J
    Zafaranloo, K
    Le Danff, C
    Carosella, ED
    FASEB JOURNAL, 2005, 19 (01): : 662 - +
  • [10] ILT3 (LILRB4) Promotes the Immunosuppressive Function of Tumor-Educated Human Monocytic Myeloid-Derived Suppressor Cells
    Singh, Latika
    Muise, Eric S.
    Bhattacharya, Anannya
    Grein, Jeff
    Javaid, Sarah
    Stivers, Peter
    Zhang, Jun
    Qu, Yujie
    Joyce-Shaikh, Barbara
    Loboda, Andrey
    Zhang, Chunsheng
    Meehl, Michael
    Chiang, Derek Y.
    Ranganath, Sheila H.
    Rosenzweig, Michael
    Brandish, Philip E.
    MOLECULAR CANCER RESEARCH, 2021, 19 (04) : 702 - 716